iron sucrose · Am Regent · NDA 021135
Venofer
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 5
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021135 · 001 · RLD | injectable, intravenous | EQ 100MG IRON/5ML (EQ 20MG IRON/ML) | open |
| 021135 · 002 · RLD | injectable, intravenous | EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML) | open |
| 021135 · 003 · discontinued | injectable, intravenous | EQ 75MG IRON/3.75ML (EQ 20MG IRON/ML) | open |
| 021135 · 004 · RLD | injectable, intravenous | EQ 200MG IRON/10ML (EQ 20MG IRON/ML) | open |
| 021135 · 005 · discontinued | injectable, intravenous | EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) | open |